PPARG and cancer: We determined the crystal structures of PPARγ LBDs containing helix H3 mutations found in cancer patients at 1.9 Å to 2.7 Å resolution with or without an SRC-1 peptide, which are monomeric or dimeric in an asymmetric unit, respectively (Table S1).